Brief Title
The Feasibility of Pertussis Immunization in a Canadian Emergency Department
Official Title
The Feasibility of Pertussis Immunization in a Canadian Emergency Department
Brief Summary
Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine to
patients presenting to the emergency department. Rates of vaccination as well as effects on
department efficiency will be measured.
Detailed Description
This study is a prospective randomized, controlled trial of two strategies to provide
patients with the pertussis vaccine. Eligible adult patients with be offered pertussis
vaccination in the Emergency Department vs. a referral to Public Health for pertussis
vaccination. The effect of both strategies on triage time as well as measure of emergency
department efficiency including length of stay, time to physician and left without being seen
rates will be compared. At a four-month follow up, rates of pertussis vaccination will be
measured.
Study Type
Interventional
Primary Outcome
Rate of immunization
Secondary Outcome
Length of Stay
Condition
Pertussis
Intervention
Tdap
Study Arms / Comparison Groups
Emergency Department vaccination group
Description: Pertussis (Tdap) vaccine offered/administered in the Emergency Department
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Behavioral
Estimated Enrollment
644
Start Date
July 10, 2017
Completion Date
December 20, 2017
Primary Completion Date
December 20, 2017
Eligibility Criteria
Inclusion Criteria:
- Adults age 18 and above
- Have not received Tdap vaccine as an adult (age 18 and above) or have not received
Tdap vaccine within 10 years, or unsure of vaccination status
Exclusion Criteria:
- Acute significant illness (Canadian Triage and Acuity Scale = 1)
- Deemed "in too much distress" by triage nurse
- Acute Febrile illness
- Allergy to vaccine or vaccine components
- Pts presenting for wound care (are normally given the vaccine as part of wound care)
- Pregnancy < 26 weeks
Gender
All
Ages
18 Years - 100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
Aaron Sibley, MD, ,
Location Countries
Canada
Location Countries
Canada
Administrative Informations
NCT ID
NCT03304275
Organization ID
6007232
Responsible Party
Sponsor
Study Sponsor
University of Prince Edward Island
Collaborators
The Queen Elizabeth Hospital
Study Sponsor
Aaron Sibley, MD, Principal Investigator, University of Prince Edward Island
Verification Date
January 2018